A review on daidzein as food supplement: Exploring its phytopharmacological and preclinical status
eFood · 2024-10 · 5 (5)
DOI: 10.1002/efd2.70008 ↗Kurz gefasst
Fachartikel in der Zeitschrift eFood, online erschienen am 25.09.2024. Verfasst von Sana Ahmad und 9 weiteren Autor:innen. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A natural product is a compound or substance originating from a living organism and found in nature. Daidzein belongs to the class of bioflavonoids, which are plant‐derived compounds with various biological activities. Predominantly exists in soybeans and several legumes in either glycoside or aglycone forms. Its primary chemical constituents include metabolites like equol and trihydroxy isoflavone, generated through the influence of intestinal bacteria. Daidzein has exhibited pharmacological impacts on different ailments, including cardiovascular disease, cancer, diabetes, skin disorders, osteoporosis, and neurodegenerative disorders. Daidzein's mechanisms of action involve interactions with estrogen receptors, as well as its antioxidant and anti‐inflammatory properties, along with its ability to regulate apoptosis and the cell cycle. In efforts to enhance its solubility, stability, bioavailability, and targeting, daidzein has been innovatively formulated into novel dosage forms, including nanoparticles, liposomes, microemulsions, and nanosuspensions. As a promising nutraceutical, daidzein presents multiple health benefits and holds potential for various clinical applications. Additional investigation is required to comprehend the molecular mechanisms of this phenomenon and assess its safety. The purpose of this review is to provide a short description of the therapeutic properties, chemical composition, traditional use, toxicology profile, new insights on the dosage form, and future prospects of daidzein.
Zitieren
APA
Ahmad, S., Ahsan, F., Ansari, J. A., Mahmood, T., Shamim, A., Bano, S., Tiwari, R., Ansari, V. A., Shafiurrahman, & Kesari, M. (2024). A review on daidzein as food supplement: Exploring its phytopharmacological and preclinical status. eFood, 5(5). https://doi.org/10.1002/efd2.70008
Vancouver
Ahmad S, Ahsan F, Ansari JA, Mahmood T, Shamim A, Bano S, et al. A review on daidzein as food supplement: Exploring its phytopharmacological and preclinical status. eFood. 2024;5(5). doi:10.1002/efd2.70008
BibTeX
@article{Ahmad2024,
author = {Ahmad, Sana and Ahsan, Farogh and Ansari, Javed Akhtar and Mahmood, Tarique and Shamim, Arshiya and Bano, Shahzadi and Tiwari, Reshu and Ansari, Vaseem Ahamad and Shafiurrahman and Kesari, Mithilesh},
title = {A review on daidzein as food supplement: Exploring its phytopharmacological and preclinical status},
journal = {eFood},
year = {2024},
volume = {5},
number = {5},
doi = {10.1002/efd2.70008}
}
EUVIMED